DK1615628T3 - Plaster med medicinsk aktivt stof og forringet optisk synlighed på huden - Google Patents

Plaster med medicinsk aktivt stof og forringet optisk synlighed på huden

Info

Publication number
DK1615628T3
DK1615628T3 DK04726478T DK04726478T DK1615628T3 DK 1615628 T3 DK1615628 T3 DK 1615628T3 DK 04726478 T DK04726478 T DK 04726478T DK 04726478 T DK04726478 T DK 04726478T DK 1615628 T3 DK1615628 T3 DK 1615628T3
Authority
DK
Denmark
Prior art keywords
skin
patch
active substance
person
medically active
Prior art date
Application number
DK04726478T
Other languages
Danish (da)
English (en)
Inventor
Stefan Bracht
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33154271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1615628(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK1615628T3 publication Critical patent/DK1615628T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Spectrometry And Color Measurement (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
DK04726478T 2003-04-17 2004-04-08 Plaster med medicinsk aktivt stof og forringet optisk synlighed på huden DK1615628T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10317692A DE10317692A1 (de) 2003-04-17 2003-04-17 Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
PCT/EP2004/003748 WO2004091590A1 (de) 2003-04-17 2004-04-08 Medizinische wirkstoffpflaster mit verringerter optischer auffälligkeit auf der haut

Publications (1)

Publication Number Publication Date
DK1615628T3 true DK1615628T3 (da) 2009-04-06

Family

ID=33154271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04726478T DK1615628T3 (da) 2003-04-17 2004-04-08 Plaster med medicinsk aktivt stof og forringet optisk synlighed på huden

Country Status (22)

Country Link
US (3) US10653636B2 (enExample)
EP (1) EP1615628B1 (enExample)
JP (2) JP5733875B2 (enExample)
KR (1) KR101052127B1 (enExample)
CN (1) CN100450472C (enExample)
AT (1) ATE415954T1 (enExample)
AU (1) AU2004229159B2 (enExample)
BR (1) BRPI0409889B8 (enExample)
CA (1) CA2522962C (enExample)
CY (1) CY1108832T1 (enExample)
DE (2) DE10317692A1 (enExample)
DK (1) DK1615628T3 (enExample)
ES (1) ES2320550T3 (enExample)
IL (1) IL171399A (enExample)
MX (1) MXPA05010935A (enExample)
NZ (1) NZ543195A (enExample)
PL (1) PL1615628T3 (enExample)
PT (1) PT1615628E (enExample)
RU (1) RU2336866C2 (enExample)
SI (1) SI1615628T1 (enExample)
WO (1) WO2004091590A1 (enExample)
ZA (1) ZA200507034B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
DE102005010255A1 (de) * 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
EP1912795B1 (en) * 2005-08-12 2012-02-22 TCMS Transparent Beauty LLC System and method for applying a reflectance modifying agent to improve the visual attractiveness of human skin
US8942775B2 (en) 2006-08-14 2015-01-27 Tcms Transparent Beauty Llc Handheld apparatus and method for the automated application of cosmetics and other substances
US8184901B2 (en) 2007-02-12 2012-05-22 Tcms Transparent Beauty Llc System and method for applying a reflectance modifying agent to change a person's appearance based on a digital image
KR101408488B1 (ko) * 2006-12-01 2014-06-17 닛토덴코 가부시키가이샤 도네페질 함유 접착 제제의 경시적인 변색을 억제하는 방법
CN101573115B (zh) * 2006-12-01 2012-06-06 日东电工株式会社 抑制含有多奈哌齐的贴剂着色的方法、及降低多奈哌齐类似物的生成量的方法
KR20100015318A (ko) 2007-02-12 2010-02-12 릭 비. 예거 인간 피부에 정전기적으로 약제를 인가하기 위한 시스템 및 방법
US10092082B2 (en) 2007-05-29 2018-10-09 Tcms Transparent Beauty Llc Apparatus and method for the precision application of cosmetics
BRPI0912099A2 (pt) * 2008-05-30 2015-10-06 Eisai R&D Man Co Ltd preparação percutaneamente absorvível
EP2279739B2 (en) * 2008-05-30 2018-02-28 Nitto Denko Corporation Donepezil-containing patch preparation and packaging thereof
KR20180019198A (ko) * 2015-06-22 2018-02-23 존슨 앤드 존슨 컨수머 인코포레이티드 피부에 효과를 제공하기 위한 다층 국소-적용 물품
EP3932251A4 (en) * 2019-02-28 2022-03-09 Panasonic Intellectual Property Management Co., Ltd. IMAGE PROCESSING DEVICE, IMAGE PROCESSING METHOD AND FILM

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE7529365U (de) 1976-01-08 Beiersdorf Ag, 2000 Hamburg Wund schnell verband
JPS55111416A (en) * 1979-02-20 1980-08-28 Taisho Pharmaceut Co Ltd Paster
US4594276A (en) * 1984-04-09 1986-06-10 Minnesota Mining And Manufacturing Company Printed, removable body tattoos on a translucent substrate
JPH0739566B2 (ja) 1986-02-21 1995-05-01 積水化学工業株式会社 医療用粘着テープもしくはシートの製造方法
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5004510A (en) * 1989-01-30 1991-04-02 Panzhihua Iron & Steel Co. Process for manufacturing high strength railroad rails
DE4030465C2 (de) * 1990-09-26 1994-06-01 Ruschke Mona Pflaster
US5120325A (en) * 1991-06-12 1992-06-09 Fleshtones Products Co., Inc. Color-matched sterile adhesive bandages containing melanin-like pigment composition
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
US5264219A (en) * 1992-08-07 1993-11-23 Minnesota Mining And Manufacturing Company Transdermal drug delivery backing
JPH07206624A (ja) 1994-01-20 1995-08-08 Shiseido Co Ltd 皮膚外用剤
US5536263A (en) * 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
DE19519593C1 (de) * 1995-05-29 1996-08-29 Horstmann Michael Transdermales Therapeutisches System mit druckfarbenfreier Identifikation und Verfahren zu seiner Herstellung
HUP0201299A2 (en) * 1996-06-20 2002-08-28 Lavipharm Sa Device for topical treatment of acne and its method of manufacture
US6025535A (en) * 1996-10-28 2000-02-15 The Procter & Gamble Company Topsheet for absorbent articles exhibiting improved masking properties
JPH11116470A (ja) * 1997-08-12 1999-04-27 Takeda Chem Ind Ltd イデベノン含有経皮投与製剤
DE69941629D1 (de) * 1998-12-18 2009-12-17 Alza Corp Durchsichtige transdermale nicotinabgabevorrichtungen
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
MXPA02010108A (es) * 2000-04-12 2003-02-12 Procter & Gamble Dispositivos de lamina preformados adecuados para aplicacion topica.
DE10053375C1 (de) 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
US8586079B2 (en) * 2002-06-21 2013-11-19 Graphic Productions Inc. Promotional simulation for transdermal patch sampler
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut

Also Published As

Publication number Publication date
US10646453B2 (en) 2020-05-12
CA2522962C (en) 2011-11-01
MXPA05010935A (es) 2005-11-25
CN100450472C (zh) 2009-01-14
BRPI0409889A (pt) 2006-05-23
CN1826103A (zh) 2006-08-30
JP2006523637A (ja) 2006-10-19
KR101052127B1 (ko) 2011-07-26
RU2005129528A (ru) 2006-05-10
KR20050114724A (ko) 2005-12-06
US11426358B2 (en) 2022-08-30
RU2336866C2 (ru) 2008-10-27
BRPI0409889B1 (pt) 2019-12-17
IL171399A (en) 2015-02-26
ATE415954T1 (de) 2008-12-15
EP1615628B1 (de) 2008-12-03
AU2004229159B2 (en) 2010-01-28
US20070116751A1 (en) 2007-05-24
CY1108832T1 (el) 2014-07-02
CA2522962A1 (en) 2004-10-28
EP1615628A1 (de) 2006-01-18
NZ543195A (en) 2009-04-30
JP2012092133A (ja) 2012-05-17
HK1079455A1 (zh) 2006-04-07
AU2004229159A1 (en) 2004-10-28
US20190160017A1 (en) 2019-05-30
WO2004091590A1 (de) 2004-10-28
PL1615628T3 (pl) 2009-06-30
SI1615628T1 (sl) 2009-04-30
US20200206147A1 (en) 2020-07-02
US10653636B2 (en) 2020-05-19
DE10317692A1 (de) 2004-11-11
JP5733875B2 (ja) 2015-06-10
DE502004008582D1 (de) 2009-01-15
ZA200507034B (en) 2006-05-31
ES2320550T3 (es) 2009-05-25
PT1615628E (pt) 2009-03-11
BRPI0409889B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
CY1108832T1 (el) Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα
BR0102637A (pt) Curativo adesivo
DE69600065D1 (de) Dermatologische und/oder pharmazeutische Zubereitung, ihre Herstellung und Anwendung
ES2091689T3 (es) Aplicacion de la carbamazepina y de la oxcarbazepina en el tratamiento de la enfermedad de parkinson y de los sindromes parkinsonianos.
BRPI0410503B8 (pt) composição tópica e uso da composição
BR0212026A (pt) Sistema terapêutico transdérmico com fentanila ou substâncias análogas
WO2002003969A3 (de) Transdermales therapeutisches system mit hochdispersem siliziumdioxid
CL2004000674A1 (es) Sistema terapeutico transdermico que comprende al menos una sustancia activa farmaceutica, al menos un disruptor de la estructura y/o al menos un formador de estructura en una matriz comun.
ATE353655T1 (de) Myo-inositol hexaphosphat zur topischen verwendung
HUP0201788A2 (en) Multilayered film containing an active substance and made of cross-linked hydrophilic polymers
CR7786A (es) Anticuerpos neutralizantes contra gdf-8 y el uso de los mismos
BR0307025A (pt) Ministrador laminado de inseticida, e, uso do mesmo
BR0207738A (pt) Sistema terapêutico transdermal altamente flex–vel com nicotina como subst ncia ativa
ATE156350T1 (de) Peptidarzneistoffe enthaltende pellets und ihre herstellung sowie deren verwendung
CY1109726T1 (el) Δισκιο εγχρωμου πυρηνα
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
AR002975A1 (es) Utilización de por lo menos un antagonista de cgrppara la preparaciónde una composición farmacéuticao dermatológica para tratar los pruritos, algias y/o disestesias oculares y/o palpebrales como asi tambien en una composición cosmética para ojos sensibles, composición obenida y procedimiento empleando dicha composición cosmética.
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
MX9405371A (es) Derivado de naftilo.
DK0889721T3 (da) Lægemiddel til udvendig anvendelse og anvendelse af en vandig oliesmulsion til et sådant lægemiddel
BRPI0505988A (pt) formulação cosmética e/ou dermtólogica e uso da mesma
CL2004001291A1 (es) Composicion farmaceutica que comprende compuestos carbociclicos y heterociclicos; y su uso para el tratamiento o profilaxis de la infeccion por influenza.
WO2003072606A3 (en) Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use
ITBO20030261A1 (it) Unita'di irraggiamento luminoso per diagnosi e cura di problemi cutanei.